Health Intel Asia provides industry insider news coverage of strategic, high-growth healthcare industries in Asia, and its authors discuss the strategic challenges that health and senior care companies face in the China and other ASEAN economies (but mostly China’s economy). We also conduct interviews and provide timely case studies that demonstrate how American companies seeking investment from Chinese companies can do so in a strategic, legal way.
We prefer a sober approach, and at times will seem as if we are doing our utmost to dissuade you from accomplishing what you wish to do, but if you’re still here once we’ve finished doing that, we’ll tell you what we think works.
Health Intel Asia was founded in 2009 as the Asia Healthcare Blog. At that time we believed that there was no open source of information that could inform decision making for executives working across the healthcare industry spectrum in China and the Asean.
Since 2013, when Asia Healthcare Blog became Health Intel Asia, our coverage has converged to focus on senior care, hospitals, and healthcare consumers, with occasional forays into other emergin industries like IVF and telemedicine, and important issues that effect all healthcare companies in Asia, like the Chinese regulator’s increased focus on foreign healthcare companies that began in pharma in mid-2013.
Perhaps most importantly, we have always written about only those areas of business where we have some sort of skin in the game. We are not journalists, but business people, and we hope our writing reflects the concerns of other business people like us.
Beijing and Seattle Offices & Contact Information:
Rubicon Strategy Group LLC
2018 156th Avenue NE, Suite 100, Building F
Bellevue, WA 98007
Fax: 1-425-644-218515/F, Office Building A
Parkview Green 9 Dongdaqiao Road
Chaoyang District, Beijing 100020 China
Get in Touch: